Biohit Oyj Financial calendar, January 13, 2022 at 2:30 pm local time (EET)
· Biohit Oyj will release its financial statements for 2021 on Wednesday
16[th] of February 2022 at 9:30 am.
· The Annual Report, which contains the Financial Statements for 2021 and the
Report of the Board of Directors, will be published on Wednesday 30[th] of March
2022 at 9:30.
· Biohit Oyj’s Annual General Meeting has been planned for Wednesday 15[th] of
June 2022 at 2:00 pm. The Board of Directors will call the General Meeting at a
later date.
· Half year financial report for period January-June (H1) 2022 will be
published on Wednesday 10[th] of August 2022 at 9:30 am.
The published economic reports and other stock exchange releases are available
on Biohit's website
at www.biohithealthcare.com/investors (https://eur04.safelinks.protection.outlook
.com/?url=http%3A%2F%2Fwww.biohithealthcare.com%2Finvestors&data=04%7C01%7CSanna.
Kurlin%40biohit.fi%7Ce79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364
b1decf5%7C0%7C0%7C637775074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAi
LCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=7uDFWWvj4lup7uSXXVeo7
EDJ4c71OBR%2FIVMnjPOA%2BWg%3D&reserved=0). The website also contains an online
form for ordering electronic copies, which will be e-mailed to you, available at
http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases
-to-your
-email (https://eur04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.bioh
ithealthcare.com%2Finvestors%2Fstock-exchange-releases%2Forder-releases-to-your
-email&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce79379bd970246069f0608d9d50d0c93
%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C637775074284926203%7CUnknown%7CTWFp
bGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000
&sdata=T9Onb0KniS%2Flhg6rgsFua6748gimIaDtPmi%2BeUkknHU%3D&reserved=0).
Additional information:
CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com (https://eur04.safelinks.protection.outlook.com/?url=htt
p%3A%2F%2Fwww.biohithealthcare.com%2F&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce
79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C6377
75074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTi
I6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=GgUivFiD2ZOAtSif14toy%2Fyj%2FqHKdd1Vm2vTRJ4
0I4E%3D&reserved=0)
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com (https://eur04.safelinks.protection.outlook.com/?url=htt
p%3A%2F%2Fwww.biohithealthcare.com%2F&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce
79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C6377
75074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTi
I6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=GgUivFiD2ZOAtSif14toy%2Fyj%2FqHKdd1Vm2vTRJ4
0I4E%3D&reserved=0)